Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
Clinical trial NCT03137537 · TERMINATED
Trial details
- NCT number
- NCT03137537
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2020-11-18
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.